๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Vaccine

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients NCT05947071Phase 210 sites๐Ÿ“ Stanford๐Ÿ“ Atlanta๐Ÿ“ Chicago National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ ยท Tests: Standard Dose Quadrivalent Inactivated Influenza Vaccine, High Dose Quadrivalent Inactivated Influenza Vaccine Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine NCT06617715Phase 31 site๐Ÿ“ Zhengzhou Sinovac Life Sciences Co., Ltd. ยท Tests: Sinovac PCV13, Prevnarยฎ Personalized Neoantigen Peptide Vaccines for Solid Tumors NCT07002203Phase 1, Phase 21 site๐Ÿ“ Bangkok Seqker Biosciences, Inc. ยท Tests: Personalized Neoantigen Peptide Vaccine Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age NCT07516418Phase 16 sites๐Ÿ“ Griffith๐Ÿ“ Herston๐Ÿ“ Morayfield Sanofi ยท Tests: H5 Flu Investigational Medical Product (IMP) 1, H5 Flu IMP 2, H5 Flu IMP 3, RSV IMP 4, RSV IMP 5 Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site๐Ÿ“ Bethesda National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Provider Recommendation and HPV Vaccination NCT05365048NA1 site๐Ÿ“ Pasadena Kaiser Permanente ยท Tests: Local Tailoring implementation strategy, Prescribed Strategy Autologous Dendritic Cell Vaccine in Kidney Cancer NCT05127824Phase 21 site๐Ÿ“ Pittsburgh Jodi Maranchie ยท Tests: Autologous alpha-DC1/TBVA vaccine, Cabozantinib RSV Vaccination in Immunocompromised Patients. NCT06597916Phase 21 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Arexvy powder and suspension for injection Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants NCT06344065Phase 31 site๐Ÿ“ Nanning Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd ยท Tests: Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed), Diphtheria, tetanus and acellular โ€ฆ Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients NCT07895394Phase 41 site๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: RSVPreF3 vaccination Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination NCT06776692n/a1 site๐Ÿ“ Negrar IRCCS Sacro Cuore Don Calabria di Negrar ยท Tests: Qdenga Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms NCT06026800Phase 11 site๐Ÿ“ Hangzhou Sir Run Run Shaw Hospital ยท Tests: iNeo-Vac-R01 Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs NCT07242092Phase 41 site๐Ÿ“ Sรฃo Paulo University of Sao Paulo General Hospital ยท Tests: Pneumococcal Vaccine Multiple Human Papillomavirus Infections in the Development of CIN NCT06862102n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: HPV vaccine A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants NCT07573462Phase 378 sites๐Ÿ“ Estero๐Ÿ“ Fort Lauderdale๐Ÿ“ Fort Myers Pfizer ยท Tests: PG4, 20-valent pneumococcal conjugate vaccine (20vPnC) A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations NCT06585241Phase 46 sites๐Ÿ“ Atlanta๐Ÿ“ Decatur๐Ÿ“ Baton Rouge ModernaTX, Inc. ยท Tests: mRNA-1273 Variant-containing Formulation Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors NCT07583654Phase 11 site๐Ÿ“ Chengdu West China Hospital ยท Tests: CP-IL22BP mRNA intratumorally injection Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors NCT05749627NA1 site๐Ÿ“ Nanchang The First Affiliated Hospital of Nanchang University ยท Tests: Neoantigen peptide vaccine, Neoantigen-based DC immune preparation Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France NCT06881953n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Questionnaire A Study to Learn About mRNA Vaccines Against Influenza in Adults NCT07431853Phase 215 sites๐Ÿ“ Mobile๐Ÿ“ Walnut Creek๐Ÿ“ Milford Pfizer ยท Tests: Vaccine Candidate #1, Vaccine Candidate #2, Vaccine Candidate #3, Vaccine Candidate #4, Vaccine Candidate #5 Mass Vaccine and Drug Administration, Bangladesh NCT06068530Phase 42 sites๐Ÿ“ Bฤndarban๐Ÿ“ Lฤma University of Oxford ยท Tests: DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-Mโ„ข A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab NCT07422337n/a2 sites๐Ÿ“ Little Rock๐Ÿ“ Springdale Arkansas Children's Hospital Research Institute Clinical Trial of PCV24 in Infants Aged 2-23 Months NCT06800261Phase 12 sites๐Ÿ“ Jinan๐Ÿ“ Shancheng Sinovac Life Sciences Co., Ltd. ยท Tests: Sinovac PCV24, Prevnarยฎ Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama NCT05654467Phase 23 sites๐Ÿ“ Panama City๐Ÿ“ Panama City๐Ÿ“ Panama City PATH ยท Tests: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOโ€ฆ A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo. NCT06955728Phase 311 sites๐Ÿ“ Kintampo๐Ÿ“ Dodowa๐Ÿ“ Kilifi University of Witwatersrand, South Africa ยท Tests: Vaccine, Placebo Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals NCT02455479Phase 11 site๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: dAd5GNE Vaccine, Placebo A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites๐Ÿ“ Lenexa๐Ÿ“ Secaucus๐Ÿ“ Rochester GlaxoSmithKline ยท Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediuโ€ฆ Influenza Vaccine Effectiveness in Among Young Children in Taiwan NCT06446232n/a1 site๐Ÿ“ Taipei National Taiwan University Hospital Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment NCT06752044NA2 sites๐Ÿ“ Nanchang๐Ÿ“ Nanchang The First Affiliated Hospital of Nanchang University ยท Tests: Radiotherapy, PD-1 inhibitor, Neoantigen-based peptide vaccine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy